Pierrepont Therapeutics, Inc. research brief

CIK 2019360 Copy CIK

Generated Nov. 11, 2026, 12:57 p.m. from up to 100 stored Form D disclosures. A CIK identifies a filer, not a single offering.

Current stored business address: BROOKLYN NY. Reported legal jurisdiction: DELAWARE. These do not establish investor residence or where funds were deployed.

• Sept. 22, 2026 · D/A · 0002019360-26-000003 · Source evidence

  Reported offering amount: 5859876 USD. Reported amount sold: 2409876 USD.

Reviewed offering links

• No independently reviewed offering relationship is recorded. Adjacent filings are not assumed to belong to one offering.

Citation: Form D Explorer, “Pierrepont Therapeutics, Inc. research brief,” CIK 2019360, retrieved Nov. 11, 2026, 12:57 p.m.. Cite the specific accessions used. No amounts have been summed.